Healthcare provider profile · identity verified

Letisha Jolene Deibert, MD

Hospitalist · WINSTON SALEM, NC · NPI 1104346113

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	398	69
Levothyroxine Sodium	Levothyroxine Sodium	350	56
Amlodipine Besylate	Amlodipine Besylate	285	44
Gabapentin	Gabapentin	246	45
Furosemide	Furosemide	232	45
Lisinopril	Lisinopril	229	43
Trazodone Hcl	Trazodone Hcl	206	39
Metoprolol Succinate	Metoprolol Succinate	205	36
Pantoprazole Sodium	Pantoprazole Sodium	198	37
Omeprazole	Omeprazole	181	28
Eliquis	Apixaban	179	34
Tamsulosin Hcl	Tamsulosin Hcl	157	30
Sertraline Hcl	Sertraline Hcl	131	27
Losartan Potassium	Losartan Potassium	128	20
Metoprolol Tartrate	Metoprolol Tartrate	116	18
Jardiance	Empagliflozin	114	19
Alendronate Sodium	Alendronate Sodium	105	22
Tramadol Hcl	Tramadol Hcl	102	31
Duloxetine Hcl	Duloxetine Hcl	99	21
Famotidine	Famotidine	85	23
Metformin Hcl	Metformin Hcl	81	14
Finasteride	Finasteride	79	15
Risperidone	Risperidone	79	14
Spironolactone	Spironolactone	77	14
Quetiapine Fumarate	Quetiapine Fumarate	73	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	72	13
Venlafaxine Hcl Er	Venlafaxine Hcl	71	11
Albuterol Sulfate Hfa	Albuterol Sulfate	70	31
Rosuvastatin Calcium	Rosuvastatin Calcium	70	19
Clopidogrel	Clopidogrel Bisulfate	69	11
Oxycodone Hcl	Oxycodone Hcl	67	38
Buspirone Hcl	Buspirone Hcl	65	suppressed
Baclofen	Baclofen	62	suppressed
Trulicity	Dulaglutide	62	12
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	58	17
Mirtazapine	Mirtazapine	58	12
Pregabalin	Pregabalin	58	15
Tiotropium Bromide	Tiotropium Bromide	57	11
Bupropion Xl	Bupropion Hcl	55	suppressed
Montelukast Sodium	Montelukast Sodium	55	suppressed
Carvedilol	Carvedilol	51	11
Simvastatin	Simvastatin	51	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	18
Pravastatin Sodium	Pravastatin Sodium	49	suppressed
Allopurinol	Allopurinol	47	11
Arexvy	Rsvpref3 Antigen/As01e/Pf	47	46
Hydrochlorothiazide	Hydrochlorothiazide	47	suppressed
Citalopram Hbr	Citalopram Hydrobromide	44	suppressed
Lamotrigine	Lamotrigine	44	suppressed
Metformin Hcl Er	Metformin Hcl	44	suppressed
Mirabegron Er	Mirabegron	43	suppressed
Gemtesa	Vibegron	41	suppressed
Morphine Sulfate	Morphine Sulfate	41	13
Potassium Chloride	Potassium Chloride	40	13
Lorazepam	Lorazepam	38	17
Clonidine Hcl	Clonidine Hcl	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Olanzapine	Olanzapine	37	suppressed
Topiramate	Topiramate	37	suppressed
Cyclosporine	Cyclosporine	36	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	14
Propranolol Hcl Er	Propranolol Hcl	34	suppressed
Ondansetron Odt	Ondansetron	33	21
Atenolol	Atenolol	32	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	17
Lidocaine	Lidocaine	32	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	31	suppressed
Torsemide	Torsemide	31	suppressed
Aripiprazole	Aripiprazole	30	suppressed
Celecoxib	Celecoxib	30	suppressed
Ozempic	Semaglutide	30	suppressed
Glipizide	Glipizide	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	22
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	20
Donepezil Hcl	Donepezil Hcl	25	suppressed
Latanoprost	Latanoprost	25	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Buprenorphine	Buprenorphine	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	21
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	22	13
Oxycontin	Oxycodone Hcl	22	suppressed
Prednisone	Prednisone	22	14
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Hydrocortisone	Hydrocortisone	21	11
Ibuprofen	Ibuprofen	21	suppressed
Lorazepam Intensol	Lorazepam	21	16
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	20	17
Timolol Maleate	Timolol Maleate	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	19	suppressed
Metformin Er Osmotic	Metformin Hcl	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Amantadine	Amantadine Hcl	18	suppressed
Cephalexin	Cephalexin	18	13
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Ursodiol	Ursodiol	18	suppressed
Anastrozole	Anastrozole	17	suppressed
Colestipol Hcl	Colestipol Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	11
Valsartan	Valsartan	17	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Digoxin	Digoxin	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Nystatin	Nystatin	16	suppressed
Temazepam	Temazepam	16	suppressed
Trospium Chloride	Trospium Chloride	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Prednisolone Acetate	Prednisolone Acetate	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Sulfasalazine	Sulfasalazine	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Trimethoprim	Trimethoprim	13	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	12	suppressed
Azithromycin	Azithromycin	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Phenytek	Phenytoin Sodium Extended	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Prolia	Denosumab	12	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Valproic Acid	Valproic Acid	12	suppressed
Emgality Pen	Galcanezumab-Gnlm	11	suppressed
Invokana	Canagliflozin	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Nystop	Nystatin	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error